Investigation of patient factors associated with the number of transfusions required during chemotherapy for high-risk neuroblastoma.

Konno, Saori; Yanagisawa, Ryu; Kubota, Noriko; Ogiso, Yoshifumi; Nishimura, Noriyuki; Sakashita, Kazuo; Tozuka, Minoru

Konno, Saori; Yanagisawa, Ryu; Kubota, Noriko; Ogiso, Yoshifumi; Nishimura, Noriyuki; Sakashita, Kazuo; Tozuka, Minoru.

Afiliación

Konno S; Life Science Research Centre, Nagano Children's Hospital, Azumino, Japan.
Yanagisawa R; Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan.
Kubota N; Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
Ogiso Y; Life Science Research Centre, Nagano Children's Hospital, Azumino, Japan.
Nishimura N; Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan.
Sakashita K; Centre for Advanced Cell Therapy, Shinshu University Hospital, Matsumoto, Japan.
Tozuka M; Department of Laboratory Medicine, Nagano Children's Hospital, Azumino, Japan.

Vox Sang ; 117(1): 71-79, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34197634

Asunto(s)

Neuroblastoma; Trombocitopenia; Transfusión Sanguínea; Humanos; Recuento de Plaquetas; Transfusión de Plaquetas

Palabras clave

BFU-E; anaemia; clonal cell culture; colony-forming assay; thrombocytopenia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Neuroblastoma Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Vox Sang Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google